Effect of Red Cell Exchange Transfusion on Plasma Levels of Inflammatory Mediators in Sickle Cell Patients with Acute Chest Syndrome

American Journal of Hematology

Volumn 76, Issue 1, 2004, Pages 19-25

  Liem, Robert I ^a,b   O'Gorman, Maurice R ^a   Brown, Deborah L ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Acute chest syndrome; Cytokines; Exchange transfusion; Inflammation; Sickle cell disease

Indexed keywords

HEMOGLOBIN S; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; SOLUBLE VASCULAR CELL ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FEMALE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SICKLE CELL ANEMIA; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHEST PAIN; CHILD; CYTOKINES; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MALE; NEUTROPHILS; PLATELET COUNT; SYNDROME; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1;

EID: 2342627387     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20054     Document Type: Article

References (43)

1. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med 1979;139:67-69.
2. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood 1994;84:643-649.
3. Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: clinical presentation and course. Blood 1997;89:1787-1792.
4. Sprinkle RH, Cole T, Smith S, Buchanan GR. Acute chest syndrome in children with sickle cell disease: a retrospective analysis of 100 hospitalized cases. Am J Pediatr Hematol Oncol 1986;8:105-110.
5. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000;342:1855-1865.
6. Vichinsky E, Williams R, Das M, et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994;83:3107-3112.
7. Nagel RL, Platt OS. General pathophysiology of sickle cell anemia. In: Steinberg MH, Forget BG, Higgs DR, and Nagel RL, editors. Disorders of hemoglobin. Cambridge: Cambridge University Press; 2001. p 494-526.
8. Stuart MJ, Yamaja, Setty BN. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 1999;94:1555-1560.
9. Moore CM, Ehlayel M, Leiva LE, Sorensen RU. New concepts in the immunology of sickle cell disease. Ann Allergy Asthma Immunol 1996;76:383-403.
10. Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, McMillen MA. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 1998;92:2551-2555.
11. Taylor SC, Shacks SJ, Mitchell RA. In vitro lymphocyte blastogenic responses and cytokine production in sickle cell disease patients with acute pneumonia. Pediatr Infect Dis J 1996;15:340-344.
12. Lipowsky HH, Chien S. Role of leukocyte-endothelium adhesion in affecting recovery from ischemic episodes. Ann NY Acad Sci 1989;565:308-315.
13. Kasschau MR, Barabino GA, Bridges KR, Golan DE. Adhesion of sickle neutrophils and erythrocytes to fibronectin. Blood 1996; 87:771-780.
14. Shreeniwas R, Koga S, Karakurum M, et al. Hypoxia-mediated induction of endothelial cell interleukin-1α. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest 1992;90:2333-2339.
15. Natarajan M, Udden MM, McIntire LV. Adhesion of sickle red blood cells and damage to interleukin-1β stimulated endothelial cells under flow in vitro. Blood 1996;87:4845-4852.
16. Vordermeier S, Singh S, Biggerstaff J, et al. Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumor necrosis factor (TNF). Br J Haematol 1992;81:591-597.
17. Karakurum M, Shreeniwas R, Chen J, et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994;93:1564-1570.
18. Francis RB, Haywood LJ. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc 1992;84:611-615.
19. Duits AJ, Schnog JB, Lard LR, Saleh AW, Rojer RA. Elevated IL-8 levels during sickle cell crisis. Eur J Haematol 1998;61:302-305.
20. Duits AJ, Pieters RC, Saleh AW, et al. Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clin Immunol Immunopathol 1996;81:96-98.
21. Charache S, Lubin B, Reid CD (editors). Management and therapy of sickle cell disease. NIH Publication No. 92-2117. Bethesda, MD: National Institutes of Health; 1992.
22. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993;81:1109-1123,
23. Antonucci R, Walker R, Herion J, Orringer E. Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets. Am J Hematol 1990;34:44-48.
24. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 1993;81:2137-2143.
25. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000; 342:83-89.
26. Charache S. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Semin Hematol 1997;34 (Suppl 3):15-21.
27. Steinberg MH, Lu Z, Barton FB, et al. Fetal Hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Blood 1997; 89:1078-1088.
28. Raghupathy R, Haider MZ, Azizieh F, Abdelsalam R, D'Souza TM, Adekile AD. Tumor necrosis factor-α is undetectable in the plasma of SS patients with elevated Hb F. Am J Hematol 2000;64:91-94.
29. Fadlon E, Vordermeier S, Pearson TC, et al. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood 1998;91: 266-274.
30. Abboud MR, Taylor EC, Habib D, et al. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol 2000;111:482-490.
31. Setty BNY, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 1996;88:2311-2320.
32. Swerlick RA, Eckman JR, Kumar A, et al. α4β1-Integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 1993;82:1891-1899.
33. Sultana C, Shen Y, Rattan V, Johnson C, Kalra VK. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 1998;92:3924-3935.
34. Shiu Y, Udden MM, McIntire LV. Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured endothelial cells. Blood 2000;95:3232-3241.
35. Saleh AW, Hillen HFP, Duits AJ. Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy. Acta Haematol 1999;102:31-37.
36. Styles LA, Lubin B, Vichinsky E, et al. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood 1997;89:2554-2559.
37. Taylor JG 6th, Tang DC, Savage SA, et al. Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 2002;100:4303-4309.
38. Kunz Matthews M, McLeod DS, Merges C, Cao J, Lutty GA. Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy. Br J Ophthalmol 2002;86:684-690.
39. Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 92;1998:3082-3089.
40. Emre U, Miller ST, Gutierez M, Steiner P, Rao SP, Rao M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995;127:901-904.
41. Kleinman SH, Hurvtiz CG, Goldfinger D. Use of erythrocytapheresis in the treatment of patients with sickle cell anemia. J Clin Apheresis 1984;2:170-176.
42. Lanzkowsky P, Shende A, Karayalcin G, Kim YJ, Aballi AJ. Partial exchange transfusion in sickle cell anemia. Am J Dis Child 1978;132:1206-1208.
43. Talacki CA, Ballas SK. Modified method of exchange transfusion in sickle cell disease. J Clin Apheresis 1990;5:183-187.